事業提携・ライセンシング・投資・M&A動向(四半期別):Q1 2013...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2013 9
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2013 9
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2013 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2013 12
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2013 13
2.4.1 Biogen Idec To Acquire Elan’s Interest In Multiple Sclerosis Drug Tysabri For $3.25 Billion 13
2.4.2 Medtronic Completes Public Offering of Notes for $3 Billion 13
2.4.3 Cardinal Health to Acquire AssuraMed for up to $2.07 Billion 14
2.4.4 Mylan to Acquire Agila Specialties from Strides Arcolab for up to $1.85 Billion 14
2.4.5 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 14
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 15
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2013 15
3.1.1 Top M&A Deals in Q1 2013 16
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q1 2012 – Q1 2013 17
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2013 18
3.2.1 Top Initial Public Offerings in Q1 2013 19
3.2.2 Top Secondary Offerings in Q1 2013 19
3.2.3 Top PIPE Deals in Q1 2013 19
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q1 2012–Q1 2013 20
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q1 2012 – Q1 2013 21
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2013 22
3.3.1 Top Venture Financing Deals in Q1 2013 23
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 24
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 25
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q1 2012 – Q1 2013 26
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 27
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 28
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2013 29
3.3.8 Top Private Equity Deals in Q1 2013 30
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q1 2012 – Q1 2013 31
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2012 – Q1 2013 34
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2013 35
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q1 2013 36
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2013 36
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q1 2013 37
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 38
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2012 – Q1 2013 39
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2012 – Q1 2013 40
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 41
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 43
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q1 2013 44
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q1 2013 44
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q1 2013 45
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2012 – Q1 2013 46
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 47
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 48
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 49
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 50
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 51
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q1 2012 – Q1 2013 51
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q1 2012 – Q1 2013 52
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2012 – Q1 2013 53
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q1 2012 – Q1 2013 54
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q1 2012 – Q1 2013 55
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q1 2012 – Q1 2013 56
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2012 – Q1 2013 57
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 58
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2013 58
7.1.1 Oncology – Deals of the Quarter 59
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2013 60
7.2.1 Central Nervous System – Deals of the Quarter 61
7.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2013 62
7.3.1 Immunology – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2013 64
7.4.1 Infectious Disease – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2013 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2013 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2013 70
7.7.1 Respiratory – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2013 72
7.8.1 Gastrointestinal – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2013 74
7.9.1 Ophthalmology – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2013 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2013 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2013 80
8.2.1 Europe – Deals of the Quarter 81
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2013 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2013 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 92
11.1 Methodology 92
11.2 About GlobalData 93
11.3 Contact Us 93
11.4 Disclosure information 93
11.5 Disclaimer 93


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向(四半期別):Q1 2013
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
■ 発行日:2013年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160890
■ 調査対象地域:グローバル
  • Source-to-Pay(S2P)アウトソーシングの世界市場:Source-to-Contract(S2C)アウトソーシング、Procure-to-Pay (P2P) アウトソーシング
    About global S2P outsourcing S2P is an effective strategy that delegates one or more business activities to external companies (suppliers) that then administer and manage the selected activity based on defined and measurable performance criteria. It helps clients operate efficiently, reduces time to market, and helps focus on core competencies. S2P leads to the successful creation of an economical …
  • ヨーロッパの無菌包装市場
    About Aseptic Packaging Market in EuropeAseptic packaging consists of the filling of sterilized perishable items in pre-sterilized packages which is made of rigid and flexible plastics, metal, and other materials in a sterile environment. Aseptic packages ensure Extended Shelf Life (ESL) for the contents inside them and maintain their original texture, aroma, and other functional characteristics. …
  • American Electric Power Company, Inc.:発電所及び企業SWTO分析2015
    American Electric Power Company, Inc. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets …
  • 動力式芝刈り機の世界市場2016-2020
    About Power Lawn Mowers Power lawn mowers have evolved from the traditional hand-guided mowers to automatic electric mowers. Advancements in technology have led to the development of lightweight power lawn mowers and battery-powered lawn mowers. The robotic lawn mower is one such innovative product available in the market. Increasing availability of such products with improved features has contrib …
  • 世界のオイル・ガス産業における衛星通信市場動向:Global Satellite Communication Market in the Oil and Gas Industry 2014-2018
    TechNavio's analysts forecast the Global Satellite Communication market in the Oil and Gas industry to grow at a CAGR of 5.74 percent over the period 2013-2018. One of the key factors contributing to this market growth is the challenging environment of oil and gas rigs. The Global Satellite Communication market in the Oil and Gas industry has also been witnessing the use of satellite communication …
  • 電気分野プラスティックのグローバル市場動向2011-2016(Electrical Plastics – A Global Market Watch, 2011 – 2016)
    Global Market Watch: Primarily supported by application sub sectors; Protection Devices, Electric Wires and Cables and Power Capacitors the Electrical Plastics market to witness a value of US$27.2 billion by 2016. Geographical analysis shows the highest Compounded Annual Growth Rate (CAGR) of 9.6% is foreseen from Asia-Pacific region during the analysis period 2011-2016. The Americas is not way be …
  • 世界の鉱業向け金融市場動向:Global Mining Finance Market 2014-2018
    TechNavio's analysts forecast the Global Mining Finance market to grow at a CAGR of 2.63 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in investment in the Power sector by China. The Global Mining Finance market has also been witnessing the decrease in global mining deals. However, the lack in investor confidence could pose a challenge …
  • 世界のシガレット(タバコ)市場2014
    Summary “Cigarette Top Line Data 2014” is a new report by ERC that is intended to provide key top-line data about Cigarettes in 123 markets worldwide. This report provides two basic elements, namely market volumes (consumption, trade and production) by country, region and globally and market volumes by company, by country, region and globally. Key Findings - Asia and Australasia is the biggest Cig …
  • 世界の3Dディスプレイ市場(2011-2015)
    TechNavio's analysts forecast the Global 3D Display market to grow at a CAGR of 21 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing broadcast of 3D content. The Global 3D Display market has also been witnessing the increasing adoption of 3D display in the Advertising sector. However, the lack of interoperability could pose a challenge t …
  • 商用車用ターボチャージャーの世界市場2016-2020
    A turbocharger increases the power efficiency of vehicles. The other advantages of using turbochargers in vehicles are increased power output, high power to weight ratio, efficiency, and reduction in engine weight. Three key technologies are involved in turbocharging: waste gate turbo used in commercial vehicles, twin turbo, and variable geometry turbo widely used in passenger cars. Technavio’s an …
  • デジタル無線周波数メモリ(DRFM)の世界市場予測(~2022)
    The Digital Radio Frequency Memory (DRFM) market was valued at USD 613.9 Million in 2016, and is projected to reach USD 1,222.2 Million by 2022, at a CAGR of 12.16% from 2016 to 2022. Advancements in military technology have led to the development of superior air defense systems. These systems have posed a serious challenge for airborne units operating in enemy airspace leading to severe damage, a …
  • AGL Energy Limited:発電所及びSWOT分析2013
    AGL Energy Limited - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and …
  • 世界主要国のスマートグリッド用同期位相計測器市場:市場規模、価格、予測
    Synchrophasors in Smart Grid in Key Countries, Update 2014 - Market Volume, Average Price and Market Size Forecasts to 2020 Summary GlobalData, the industry analysis specialist, has released its latest research, “Synchrophasors in Smart Grid in Key Countries, Update 2014 - Market Volume, Average Price and Market Size Forecasts to 2020”, which provides in-depth analysis of the synchrophasor market …
  • リン化アルミニウムの世界市場
    Aluminium phosphide (CAS 20859-73-8) Market Research Report 2013 presents comprehensive data on aluminium phosphide markets globally and regionally (Europe, Asia, North America etc.) The Aluminium phosphide (CAS 20859-73-8) Market Research Report 2013 includes aluminium phosphide description, covers its application areas and related patterns. It overviews aluminium phosphide market, names aluminiu …
  • 世界の小売業タッチスクリーンディスプレイ市場:Global Retail Touch Screen Display Market 2014-2018
    TechNavio's analysts forecast the Global Retail Touch Screen Display market to grow at a CAGR of 30.33 percent over the period 2013-2018. One of the key factors contributing to this market growth is the use of hi-tech touch screen displays for customer engagement. The Global Retail Touch Screen Display market has also been witnessing the increasing focus on the development of multi-touch screens. …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。